3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
23
Kidney Neoplasms
10
Neoplasms
8
Carcinoma, Non-Small-Cell Lung
7
Carcinoma
6
Melanoma
4
Lung Neoplasms
4
Colorectal Neoplasms
4
Neoplasm Metastasis
3
Carcinoma, Hepatocellular
3
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Kidney Diseases
2
Clear-cell metastatic renal cell carcinoma
2
Carcinoma, Adenoid Cystic
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uveal Melanoma
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Solid Tumors
1
Skin Neoplasms
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Recurrence
1
Prostatic Neoplasms
1
Pheochromocytoma
1
Paraganglioma
1
Interventions
Temozolomide
53
Bevacizumab
33
Radiotherapy
27
Radiation
12
Erlotinib Hydrochloride
12
Radiotherapy, Intensity-Modulated
8
Radiotherapy, Conformal
8
Irinotecan
6
Vorinostat
5
Sorafenib
5
Sirolimus
5
temsirolimus
4
Magnetic Resonance Spectroscopy
4
Immunoglobulin G
4
Disulfides
4
Carmustine
4
veliparib
3
plerixafor
3
carmustine, poliferprosan 20 drug combination
3
Radiosurgery
3
Everolimus
3
Dasatinib
3
Bortezomib
3
vandetanib
2
tandutinib
2
sargramostim
2
poly ICLC
2
pembrolizumab
2
pazopanib
2
ferric pyrophosphate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Gliosarcoma
×
Axitinib
×
Clear all
No trials found.